Jean-Baptiste Davion1, Caroline Jougleux2, Renaud Lopes1, Xavier Leclerc1, Olivier Outteryck3. 1. Department of Neuroradiology, Univ. Lille, INSERM, CHU Lille, U1172, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France. 2. Department of Neurology, Multiple Sclerosis Center of Lille, Univ. Lille, 59000, Lille, France. 3. Department of Neuroradiology, Univ. Lille, INSERM, CHU Lille, U1172, Degenerative and Vascular Cognitive Disorders, 59000, Lille, France. olivier.outteryck@chru-lille.fr.
Abstract
INTRODUCTION: Asymptomatic optic nerve lesions are frequent in multiple sclerosis (MS) and their impact on cognition and/or brain volume has never been taken into account. PATIENTS AND METHODS: We used the data from the cross-sectional Visual Ways in MS (VWIMS) study including relapsing remitting MS. All patients underwent brain and optic nerve Magnetic Resonance Imaging (MRI) including Double Inversion Recuperation (DIR) sequence, retinal OCT, and cognitive evaluation with the Brief International Cognitive Assessment in MS (BICAMS). We measured the association between OCT findings (thickness/volume of retinal layers) and extra-visual parameters (cerebral volumes and BICAMS scores) in optic nerves with and/or without the presence of DIR asymptomatic optic nerve hypersignal. RESULTS: Between March and December 2017, we included 98 patients. Two patients were excluded. Over the 192 eyes, 73 had at least one clinical history of optic neuritis (ON-eyes) whereas 119 were asymptomatic (NON-eyes). Among the 119 NON-eyes, 58 had 3D-DIR optic nerve hypersignal (48.7%). We confirmed significant associations between some retinal OCT measures and some extra-visual parameters (cerebral volumes, cognitive scores) in NON-eyes. Unexpectedly, these associations were found when an asymptomatic optic nerve DIR-hypersignal was present on MRI, but not when it was absent. CONCLUSION: Our study showed a relation between OCT measures and extra-visual parameters in NON-eyes MS patients. As a confusion factor, asymptomatic optic nerve lesions may be the explanation of the relation between OCT measures and extra-visual parameters. Retinal OCT seems to be far more a "window over the optic nerve" than a "window over the brain".
INTRODUCTION: Asymptomatic optic nerve lesions are frequent in multiple sclerosis (MS) and their impact on cognition and/or brain volume has never been taken into account. PATIENTS AND METHODS: We used the data from the cross-sectional Visual Ways in MS (VWIMS) study including relapsing remitting MS. All patients underwent brain and optic nerve Magnetic Resonance Imaging (MRI) including Double Inversion Recuperation (DIR) sequence, retinal OCT, and cognitive evaluation with the Brief International Cognitive Assessment in MS (BICAMS). We measured the association between OCT findings (thickness/volume of retinal layers) and extra-visual parameters (cerebral volumes and BICAMS scores) in optic nerves with and/or without the presence of DIR asymptomatic optic nerve hypersignal. RESULTS: Between March and December 2017, we included 98 patients. Two patients were excluded. Over the 192 eyes, 73 had at least one clinical history of optic neuritis (ON-eyes) whereas 119 were asymptomatic (NON-eyes). Among the 119 NON-eyes, 58 had 3D-DIR optic nerve hypersignal (48.7%). We confirmed significant associations between some retinal OCT measures and some extra-visual parameters (cerebral volumes, cognitive scores) in NON-eyes. Unexpectedly, these associations were found when an asymptomatic optic nerve DIR-hypersignal was present on MRI, but not when it was absent. CONCLUSION: Our study showed a relation between OCT measures and extra-visual parameters in NON-eyes MS patients. As a confusion factor, asymptomatic optic nerve lesions may be the explanation of the relation between OCT measures and extra-visual parameters. Retinal OCT seems to be far more a "window over the optic nerve" than a "window over the brain".
Authors: Hanna Zimmermann; Alina Freing; Falko Kaufhold; Gunnar Gaede; Elena Bohn; Markus Bock; Timm Oberwahrenbrock; Kim-Lea Young; Jan Dörr; Jens T Wuerfel; Sven Schippling; Friedemann Paul; Alexander U Brandt Journal: Mult Scler Date: 2012-08-30 Impact factor: 6.312
Authors: Axel Petzold; Laura J Balcer; Peter A Calabresi; Fiona Costello; Teresa C Frohman; Elliot M Frohman; Elena H Martinez-Lapiscina; Ari J Green; Randy Kardon; Olivier Outteryck; Friedemann Paul; Sven Schippling; Patrik Vermersch; Pablo Villoslada; Lisanne J Balk Journal: Lancet Neurol Date: 2017-09-12 Impact factor: 44.182
Authors: Fiona Costello; Stuart Coupland; William Hodge; Gianni R Lorello; Jeannie Koroluk; Y Irene Pan; Mark S Freedman; David H Zackon; Randy H Kardon Journal: Ann Neurol Date: 2006-06 Impact factor: 10.422
Authors: Elliot M Frohman; Michael G Dwyer; Teresa Frohman; Jennifer L Cox; Amber Salter; Benjamin M Greenberg; Sara Hussein; Amy Conger; Peter Calabresi; Laura J Balcer; Robert Zivadinov Journal: J Neurol Sci Date: 2009-05-12 Impact factor: 3.181
Authors: E Gordon-Lipkin; B Chodkowski; D S Reich; S A Smith; M Pulicken; L J Balcer; E M Frohman; G Cutter; P A Calabresi Journal: Neurology Date: 2007-10-16 Impact factor: 9.910
Authors: Erica Grazioli; Robert Zivadinov; Bianca Weinstock-Guttman; Norah Lincoff; Monika Baier; Jan Rang Wong; Sara Hussein; Jennifer L Cox; David Hojnacki; Murali Ramanathan Journal: J Neurol Sci Date: 2007-12-04 Impact factor: 3.181
Authors: Jan Dörr; Klaus D Wernecke; Markus Bock; Gunnar Gaede; Jens T Wuerfel; Caspar F Pfueller; Judith Bellmann-Strobl; Alina Freing; Alexander U Brandt; Paul Friedemann Journal: PLoS One Date: 2011-04-08 Impact factor: 3.240
Authors: S Anand Trip; Patricio G Schlottmann; Stephen J Jones; Daniel R Altmann; David F Garway-Heath; Alan J Thompson; Gordon T Plant; David H Miller Journal: Ann Neurol Date: 2005-09 Impact factor: 10.422